asa glp-1 agonist guidelines How should we approach patients on agonists? Check out this excellent editorial from Dr. Girish Joshi, "Clarifying the and Decoding the Enigma: Strategies for Anesthetic Management of Patients on Glucagon-Like Holding GLP-1 Agonists Prior to

In albino patients, the body has an abnormal gene, which restricts the body from producing melanin, the pigment that gives skin its color

This combination is claimed to accelerate fat metabolism and reduce inflammation, though it lacks the extensive clinical history and regulatory backing of established alternatives

CPT1 is a mitochondrial importer of fatty acids

In Parkinson's disease, oxidative stress plays a role in damaging the neurons that produce dopamine, a crucial brain chemical

Various neurodegenerative disorders are characterized by the depletion of cellular GSH, probably due to its counteracting oxidative stress and calcium ion (Ca 2+ ) imbalance [53]